SUN Pharma Canada Inc. Pharmaceutical Import Profile — Canada (DGFT 2022–2026)

Name: SUN Pharma Canada Inc. Pharmaceutical Import Records from India — 8 Products, $8.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

SUN Pharma Canada Inc. — Pharmaceutical Importer Profile (2026) | 8 Products, $8.7M Trade | TransData Nexus

SUN Pharma Canada Inc.

Pharmaceutical Importer · Canada · Gastrointestinal Focus · $8.7M Total Trade · DGFT Verified

SUN Pharma Canada Inc. is a pharmaceutical importer based in Canada with a total trade value of $8.7M across 8 products in 5 therapeutic categories. Based on 205 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. SUN Pharma Canada Inc. sources from 1 verified Indian supplier, with Sun Pharmaceutical Industries Limited accounting for 100.0% of imports.

SUN Pharma Canada Inc. — Import Portfolio & Supplier Network

SUN Pharma Canada Inc. import network — 8 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to SUN Pharma Canada Inc.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Sun Pharmaceutical Industries Limited	$7.1M	301	100.0%

SUN Pharma Canada Inc. sources from 1 verified Indian supplier across 187 distinct formulations. The sourcing is highly concentrated — Sun Pharmaceutical Industries Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Ramipril and hydrochlorothiazide	$345.8K	12
Esomeprazole magnesium gastro	$331.1K	10
Taro-cefprozil TAB 500MG Pack: 100s	$264.2K	6
Taro apixaban TAB 5MG cd 60btl (30404	$150.0K	3
Taro apixaban TAB 5MG cd 180btl (20196	$150.0K	3
Taro apixaban tablets 5MG (30785 bottlex 180 tabs) batch no. apxtb2401a; apxtb2402a & apxtb2403a, mfg dt. 03/24 exp dt.	$150.0K	3
Ran-esomeprazole tablets 40MG (Each tablet contains: esomeprazole magnesium equivalent to 40MG) [6366 Pack x 100's	$150.0K	3
Taro apixaban tablets 5MG [10053 Pack	$100.0K	2
Taro-cefprozil TAB 250MG Pack: 100s	$100.0K	2
Taro-cefprozil SUSP 250MG/5ML Pack	$100.0K	2
Ran-esomeprazole TAB 40MG Pack: 100s	$100.0K	2
Apo-esomeprazole TAB 40MG 500 bottle	$100.0K	2
Ran-ezetimibe TAB 10MG Pack: 500s	$74.0K	2
Ramipril and hydrochlorothiazide tablets5+12.5MG (taro ramipril+hctz TAB 5+12.5MG)Each	$73.8K	6
Esomeprazole magnesium gastro resistanttablets 40MG (apo-esomeprazole tablets 40MG) [7032 packs x 100's] (batch no.	$69.5K	3

Import Portfolio — Top 8 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Esomeprazole	Gastrointestinal	$4.3M	86	0.4%	2
2	Magnesium	Vitamins & Supplements	$1.4M	29	0.4%	2
3	Gliclazide	Advanced Diabetes Medications	$1.4M	27	0.4%	11
4	Ramipril	Cardiovascular	$945.4K	49	1.1%	19
5	Omeprazole	Gastrointestinal	$350.0K	7	0.1%	2
6	Sunitinib	Advanced Oncology	$150.0K	3	0.2%	5
7	Calcium	Vitamins & Supplements	$100.0K	2	0.0%	8
8	Rosuvastatin	Cardiovascular	$100.0K	2	0.0%	6

SUN Pharma Canada Inc. imports 8 pharmaceutical products across 5 categories into Canada totaling $8.7M.

SUN Pharma Canada Inc. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Sun Pharma Canada Inc. is a subsidiary of Sun Pharmaceutical Industries Limited, a leading global specialty generic pharmaceutical company headquartered in Mumbai, India. Established in 1983, Sun Pharma has grown to become the largest pharmaceutical company in India and the fifth-largest specialty generic pharmaceutical company worldwide. Sun Pharma Canada Inc. operates from Brampton, Ontario, focusing on providing innovative and affordable medicines in dermatology, ophthalmology, and oncology. (lifesciencesontario.ca) The company's portfolio includes products such as Ilumya, Winlevi, Absorica LD, and Cequa, aiming to address unmet needs in the Canadian healthcare market. (lifesciencesontario.ca)

2Distribution Network

Sun Pharma Canada Inc. maintains its distribution operations from its Brampton, Ontario facility. While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, the company's global manufacturing footprint includes over 40 facilities across five continents, ensuring a robust supply chain to meet the needs of the Canadian market. This extensive network supports the efficient distribution of pharmaceutical products throughout Canada.

3Industry Role

In Canada's pharmaceutical supply chain, Sun Pharma Canada Inc. functions primarily as a wholesaler and distributor. The company imports finished pharmaceutical formulations from its parent company, Sun Pharmaceutical Industries Limited, and other suppliers, facilitating the availability of these products to healthcare providers and patients across Canada. By focusing on the importation and distribution of specialized medicines, Sun Pharma Canada Inc. plays a crucial role in enhancing access to innovative therapies within the Canadian healthcare system.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — SUN Pharma Canada Inc.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Sun Pharma Canada Inc. exhibits a high degree of supplier concentration, sourcing 100% of its imported pharmaceutical formulations from Sun Pharmaceutical Industries Limited. This single-source dependency indicates a strategic choice to leverage the parent company's extensive manufacturing capabilities and established product portfolio. The stability of this relationship is evidenced by the consistent importation of 205 shipments over the 2022-2026 period, reflecting a reliable and ongoing partnership. However, this concentration also presents potential risks, such as exposure to supply chain disruptions or regulatory changes affecting the parent company's operations.

2Supply Chain Resilience

The resilience of Sun Pharma Canada Inc.'s supply chain is closely tied to the operations of Sun Pharmaceutical Industries Limited. With over 40 manufacturing facilities worldwide, Sun Pharma has a diversified production base that can mitigate risks associated with regional disruptions. Additionally, the company's adherence to Good Manufacturing Practices (GMP) and compliance with regulatory standards across various markets, including Canada, ensures the quality and reliability of its products. While the reliance on a single supplier may limit diversification, the robust infrastructure and regulatory compliance of Sun Pharmaceutical Industries Limited contribute to the overall resilience of the supply chain.

Importing Pharmaceuticals into Canada — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Canada

1Regulatory Authority & Framework

In Canada, the regulation of pharmaceutical products is overseen by Health Canada, the federal department responsible for national public health. The Food and Drugs Act and its associated regulations govern the importation, sale, and distribution of drugs in Canada. Pharmaceutical importers must obtain an Establishment Licence (EL) from Health Canada, which authorizes them to import and distribute drugs. Additionally, each drug product must have a Drug Identification Number (DIN), indicating that it has been reviewed and approved by Health Canada for safety, efficacy, and quality. (canada.ca)

2Import Licensing & GMP

To import pharmaceutical products into Canada, companies must hold an Establishment Licence (EL) issued by Health Canada. This licence permits the importation and distribution of drugs within the country. The foreign manufacturing site must be listed on the importer's EL, ensuring that the manufacturing facilities comply with Health Canada's requirements. Good Manufacturing Practices (GMP) certification is essential, as it ensures that pharmaceutical products are consistently produced and controlled according to quality standards. Recognized GMP certifications include those from the European Union (EU GMP), World Health Organization (WHO GMP), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must verify that their suppliers hold valid GMP certifications from recognized authorities to maintain compliance with Canadian regulations. (canada.ca)

SUN Pharma Canada Inc. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Sun Pharma Canada Inc. focuses on importing pharmaceutical products in the gastrointestinal, vitamins & supplements, and advanced diabetes medications categories. The company's top five imported products—Esomeprazole, Magnesium, Gliclazide, Ramipril, and Omeprazole—align with these therapeutic areas, indicating a strategic emphasis on addressing prevalent health conditions in Canada. The significant import values in these categories suggest a strong market demand and the company's commitment to providing essential treatments to Canadian patients.

2Sourcing Profile

Sun Pharma Canada Inc. primarily sources generic pharmaceutical formulations from its parent company, Sun Pharmaceutical Industries Limited. This sourcing strategy leverages the parent company's extensive manufacturing capabilities and established product portfolio, ensuring a consistent supply of high-quality medicines. The focus on finished pharmaceutical formulations, rather than active pharmaceutical ingredients (APIs) or bulk drugs, indicates a preference for ready-to-market products that can be directly distributed to healthcare providers and patients in Canada.

3Market Positioning

Seller's Guide — How to Become a Supplier to SUN Pharma Canada Inc.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Sun Pharma Canada Inc., provided they can meet the stringent quality and regulatory standards required by Health Canada and Sun Pharmaceutical Industries Limited. Potential suppliers should possess valid GMP certifications from recognized authorities such as the EU, WHO, or PIC/S. Additionally, demonstrating the ability to supply high-quality finished pharmaceutical formulations that align with the therapeutic areas of interest to Sun Pharma Canada Inc. will enhance the prospects of establishing a successful partnership.

2Requirements & Qualifications

Indian exporters seeking to supply Sun Pharma Canada Inc. and the Canadian market must obtain GMP certifications from recognized authorities, including the European Union (EU GMP), World Health Organization (WHO GMP), or the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Additionally, compliance with Health Canada's regulations, including obtaining an Establishment Licence and ensuring that foreign manufacturing sites are listed on the importer's licence, is essential. Products must also meet Health Canada's requirements for Drug Identification Numbers (DINs) and adhere to labeling standards in both English and French. (canada.ca)

Frequently Asked Questions — SUN Pharma Canada Inc.

What products does SUN Pharma Canada Inc. import from India?

SUN Pharma Canada Inc. imports 8 pharmaceutical products across 5 categories. Top imports: Esomeprazole ($4.3M), Magnesium ($1.4M), Gliclazide ($1.4M), Ramipril ($945.4K), Omeprazole ($350.0K).

Who supplies pharmaceuticals to SUN Pharma Canada Inc. from India?

SUN Pharma Canada Inc. sources from 1 verified Indian suppliers. The primary supplier is Sun Pharmaceutical Industries Limited (100.0% of imports, $7.1M).

What is SUN Pharma Canada Inc.'s total pharmaceutical import value?

SUN Pharma Canada Inc.'s total pharmaceutical import value from India is $8.7M, based on 205 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does SUN Pharma Canada Inc. focus on?

SUN Pharma Canada Inc. imports across 5 categories. The largest: Gastrointestinal (53.2%), Vitamins & Supplements (17.7%), Advanced Diabetes Medications (15.4%).

Get Full SUN Pharma Canada Inc. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

SUN Pharma Canada Inc.

SUN Pharma Canada Inc. — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to SUN Pharma Canada Inc.?

What Formulations Does SUN Pharma Canada Inc. Import?

What Products Does SUN Pharma Canada Inc. Import?

Top Products by Import Value

SUN Pharma Canada Inc. Therapeutic Categories — 5 Specializations